Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

China Surprises With First CRISPR Trial Despite Regulatory Lag, Concerns

Jul 26 2016

• By Brian Yang

CRISPR_Diagram_1200

Related Content

SAD, BAD Or DAD? Insiders See Risks Increasing In China IO Rush

May 31 2016

Scrip's Rough Guide To CRISPR Gene Editing

Jun 28 2016

Related Companies

Editas Medicine

CRISPR Therapeutics AG

Intellia Therapeutics, Inc.

Merck & Co., Inc.

Bristol Myers Squibb Company

Additional Topics

Asia Pacific China Research & Development BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window